0.50 Hours
This session describes the various types of pain experienced by cancer patients and reviews the causes of these pain types, generally, and with reference to specific pathophysiological mechanisms.
0.50 Hours
This session describes the assessment of pain in paediatric practice highlighting the different methodologies used when assessing acute and chronic pain.
0.50 Hours
This session reviews the pharmacology of some of the common drugs used to treat neuropathic pain and considers the practical aspects of using these drugs, including a review of the current evidence for their use.
0.50 Hours
This session describes the common chronic pain conditions of post-herpetic neuralgia, painful diabetic peripheral neuropathy, HIV-related and AIDS-related pain and trigeminal neuralgia.
0.50 Hours
This session describes the symptoms and signs associated with neuropathic pain, its diagnosis and the multimodal approach to its treatment.
0.50 Hours
This session provides an overview of the most common chronic pain conditions.
0.50 Hours
This session describes the types of CRPS, the criteria used for diagnosis, pathophysiology, principles of management and recent research on CRPS.
0.50 Hours
This session covers the pharmacology and uses of weak opioids such as codeine, partial agonist and mixed agonist/antagonist drugs, and problems associated with their use. It also examines the pharmacology and use of μ receptor antagonists.
0.50 Hours
This session explores the pharmacokinetic and pharmacodynamic properties of the aminosteroid neuromuscular blocking agents (NMBAs). It explores: the relationship between the chemical structure of these agents, their potency and their route of elimination; the relationship between potency and rate of onset; the use of neuromuscul....
0.50 Hours
This session is about the benzylisoquinolinium neuromuscular blocking agents. The session also compares the currently available benzylisoquinoliniums with the ideal muscle relaxant, and considers the relationship between structure and the pharmacological properties of these drugs. Finally, the session highlights the cardiovascul....
0.50 Hours
This session describes drugs that act on the H1 receptor to counteract the effects of histamine, explores the indications, mechanism of action, side-effect profiles and the reasons for the various indications of commonly encountered antihistamines.
0.50 Hours
This session describes the pharmacology and management of anticoagulants.
0.50 Hours
This session will enable you to understand the differences in cell structure between bacteria and human cells. Antibiotics exploit these differences so they can target bacteria without causing harm to host cells. Antibiotics can either affect cell wall synthesis, protein synthesis, DNA replication and can also inhibit various en....
0.50 Hours
This session covers density and viscosity and the implications of these on the measurement of flow, as well as the physical properties of the gases commonly used in clinical practice.
0.50 Hours
Anaesthetic practice involves the extensive daily use of equipment. Routine checking of this equipment is essential in the safe delivery of anaesthetic care. This session provides an overview of the principles of checking the anaesthetic equipment used in current common practice, in accordance with the recommendations of the Ass....
0.50 Hours
Epidural anaesthesia is a very popular central neuraxial block technique used worldwide. Various designs of needles, catheters, filters and loss-of-resistance devices have been used. This session explores the history of the equipment used in epidural anaesthesia and provides an overview of the basic design of epidural needles, l....
0.50 Hours
Myasthenia gravis (MG) is an autoimmune condition in which IgG autoantibodies interact with the postsynaptic acetylcholine receptors (AChR) at the nicotinic neuromuscular junction (NMJ).
In this session, you will discover features specific to various causes of pulmonary hypertension (PHT), treatment of these causes and the role of imaging in the follow-up of specific cases of PHT.
0.50 Hours
Valvular heart disease may be poorly tolerated in pregnancy; its recognition, assessment and management is detailed in this session.
0.50 Hours
An overview of the causes, investigation and immediate management of the comatose patient.
An introduction to pregnancy associated changes in pharmacology and the effects of drugs upon the uterus and fetus.
0.50 Hours
This session will discuss the management of critically ill patients with abnormalities in serum potassium (K+), magnesium (Mg2+) and phosphate (PO42-).
0.50 Hours
This session will cover the role of imaging in diagnosis and management of acute pancreatitis, along with complications and the role of interventional radiology management of the patient.
0.50 Hours
Intestinal failure is a specific disease entity resulting from intestinalresection or disease-associated malabsorption and characterized by theinability to maintain protein-energy, fluid, electrolyte or micronutrientbalance.
0.50 Hours
This session describes the pathophysiology, diagnosis and initial management priorities in newly diagnosed acute myeloid leukaemia (AML) and complications that may require critical care input. It also covers how concurrent AML and its treatment may impact on critical illness.